These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2935175)

  • 1. Peripheral arterial diseases: treatment with ketanserin as i.v. infusion. An open study in 20 patients.
    Di Giovanni V; Colli R
    Boll Chim Farm; 1985 Oct; 124(10):129S-132S. PubMed ID: 2935175
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative blood flow of the calf in arterial occlusive diseases of the combined and femoral type during intravenous and intra-arterial administration of Mydocalm].
    Hackel F
    Z Gesamte Inn Med; 1968 Feb; 23(4):109-17. PubMed ID: 5686874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ketanserin in the treatment of ischemic disease of the lower extremities].
    Gerová Z; Brimichová E; Dzúrik R
    Cas Lek Cesk; 1985 Jul; 124(30):938-41. PubMed ID: 3161617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of nifedipine on peripheral blood flow in patients with atherosclerotic arterial disease of the lower limbs. A controlled study].
    Savi L; Cardillo C; Guerrera G; Melina D
    Clin Ter; 1985 Mar; 112(5):419-22. PubMed ID: 4017466
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous imaging of regional blood flow in peripheral vascular disease using Krypton-81m: effect of Ketanserin, a new selective serotonin antagonist.
    Gerritsen HA; Perquin JW; de Smet HL; Troost FA; Kotora OV
    Diagn Imaging; 1983; 52(2-3):85-92. PubMed ID: 6851822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated with intermittent claudication.
    Fares CM; Milliken JC
    Curr Med Res Opin; 1974; 2(2):57-62. PubMed ID: 4151332
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
    van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
    Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is prevention of hypertension after open heart surgery possible by blocking 5HT2-receptors with ketanserin?
    van den Broeke JJ; Karliczek GF; Brenken U; Schokkenbroek R; Homan van der Heide JN
    Acta Anaesthesiol Belg; 1982; 33(2):115-20. PubMed ID: 6981913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra arterial ketanserin in peripheral vascular disease.
    Boas RA
    Angiology; 1986 Apr; 37(4):267-71. PubMed ID: 2940946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the regional circulation of arteriosclerosis patients during treatment with dextro-thyroxine].
    Furitano G; Salerno L; Cerasola GA; Custro N
    Boll Soc Ital Biol Sper; 1974 Aug; 50(16-2):1273-6. PubMed ID: 4458714
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery.
    van der Starre PJ; Scheijgrond HW; Reneman RS; Kolling JB
    Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotonin antagonists in the treatment of hypertension].
    Fetkovská N; Brimichová G; Tison P; Dzúrik R
    Cas Lek Cesk; 1984 Mar; 123(11):322-5. PubMed ID: 6367991
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On a method of treating patients with obliterating diseases of the arteries by the prolonged intra-arterial administration of medicinal substances].
    Nazarov GD
    Vestn Khir Im I I Grek; 1969 Jan; 102(1):55-60. PubMed ID: 5785818
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism.
    De Lorenzo A; Ceccanti M; Romeo M; Pisculli M; Di Giovanni MG; Lais A; Assogna G; Valgiusti FC
    Int J Clin Pharmacol Res; 1986; 6(1):77-9. PubMed ID: 2937747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B; Elmér O; Akesson A
    Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional haemodynamics and antihypertensive effects during long-term ketanserin treatment.
    Persson B; Petterson A; Andersson O; Berglund G; Hedner T
    J Hypertens Suppl; 1986 Apr; 4(1):S99-101. PubMed ID: 2939223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.